1-20 of 77
Juan Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world study on discontinuation strategies after MRD negativity in multiple myeloma patients

Free
Xiaozhe Li, Juan Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 2209.
https://doi.org/10.1182/blood-2025-2209
Published: 2025
Journal Articles

Real-world stratified treatment strategies in transplant-eligible newly diagnosed multiple myeloma: A multicohort study

Free
Lifen Kuang, Juan Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7541.
https://doi.org/10.1182/blood-2025-7541
Published: 2025
Journal Articles

Aponermin-based regimen as bridging therapy prior to CAR-T cell therapy for relapsed/refractory multiple myeloma

Free
Junru Liu, Juan Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7534.
https://doi.org/10.1182/blood-2025-7534
Published: 2025
Journal Articles

Efficacy and safety of aponermin combined with immunomodulators in relapsed/refractory multiple myeloma

Free
Xiujuan Huang, Yanping Ma, Zhenyu Li, Juan Li, Yuzhang Liu, Yaomei Wang, Chao Song, Xiaoqi Qin, Wenming Chen, Yi Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 7571.
https://doi.org/10.1182/blood-2025-7571
Published: 2025
Journal Articles

Real-world safety and efficacy of aponermin and selinexor-based regimens in patients with multiple myeloma

Free
Xiaozhe Li, Chengcheng Fu, Chunrui Li, Song Jin, Di Wang, Huixing Zhou, Jingjing Shang, Guangzhong Yang, Wenming Chen, Juan Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7588.
https://doi.org/10.1182/blood-2025-7588
Published: 2025
Journal Articles

A multimodal machine learning framework to predict treatment duration in multiple myeloma patients

Free
Frederick Shi, Xinyi Yang, Juan Li, Shijing Wang, Bin Sun, Jing Dong, Peiman Hematti, Siegfried Janz, Anita D'Souza, Laura Michaelis, Binod Dhakal, Fumou Sun
Journal: Blood
Blood (2025) 146 (Supplement 1): 5715.
https://doi.org/10.1182/blood-2025-5715
Published: 2025
Journal Articles

Exploration of the role of macrophage mitochondrial damage-mediated excessive pyroptosis in ITP

Free
Guoyang Zhang, Hongyun Liu, Ziyang Liang, Xiaoyan Liu, Jie Xiao, Wenjuan Yang, Danian Nie, Juan Li, Liping Ma
Journal: Blood
Blood (2025) 146 (Supplement 1): 3023.
https://doi.org/10.1182/blood-2025-3023
Published: 2025
Journal Articles

Real-world safety and efficacy of aponermin and daratumumab-based regimens in patients with multiple myeloma

Free
Xiaozhe Li, Baijun Fang, Di Wang, Yuzhang Liu, Yanping Ma, Peiling Zhang, Aijun Liu, Wenming Chen, Juan Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7580.
https://doi.org/10.1182/blood-2025-7580
Published: 2025
Journal Articles

Impact of pomalidomide-containing induction chemotherapy on hematopoietic stem cell mobilization in multiple myeloma: A retrospective cohort study

Free
Lifen Kuang, Juan Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7545.
https://doi.org/10.1182/blood-2025-7545
Published: 2025
Journal Articles

Role of IL-10 in regulating macrophage pyroptosis in immune thrombocytopenia

Free
Ziyang Liang, Xiaoyan Liu, Guoyang Zhang, Hongyun Liu, Shuangfeng Xie, Yiqing Li, Juan Li, Danian Nie, Liping Ma
Journal: Blood
Blood (2025) 146 (Supplement 1): 4798.
https://doi.org/10.1182/blood-2025-4798
Published: 2025
Journal Articles

Safety and Efficacy of Dara-Based Regimen Followed with ASCT in Transplant-Eligible, Newly-Diagnosed Systemic Light Chain Amyloidosis

Free
Can Le, Juan Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6875.
https://doi.org/10.1182/blood-2024-202233
Published: 2024
Journal Articles

Clinical Feature and Predictive Model for Transplanted Patients with Functional High-Risk Multiple Myeloma

Free
Tongyong Yu, Juan Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4727.
https://doi.org/10.1182/blood-2024-202216
Published: 2024
Journal Articles

Predictors and MRD-Driven Treatment Strategies of Unsustained Measurable Residual Disease Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma

Free
Xiaozhe Li, Juan Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4710.
https://doi.org/10.1182/blood-2024-202210
Published: 2024
Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Free
Chuanying Geng, Jing Lu, Xiaozhe Li, Qiang Li, Na Li, Weiwei Tian, Jie Zhao, Guangzhong Yang, Yanping Ma, Xiaoqi Qin, Jing Jia, Huixing Zhou, Lintao Bi, Chenchen Wang, Ying Sun, Xiantao Liu, Yuan Jian, Qingming Wang, Haixiang Wan, Jinqiao Zhang, Han Liu, Hui Geng, Xiaojing Ma, Yunxia Liang, Rui Hu, Da Gao, Donghai Han, Haisheng Liu, Guangyu Ma, Zhihua Zhang, Wei Wang, Shi Minxia, Bo Nie, Zhang Hong, Jie Li, Guitao Jie, Meiying Fan, Qinglin Song, Wenyong Li, Zhenfang Xi, Guorong Gao, Jie Liu, Zhihua Li, Hua Xue, Huimei Guo, Jie Li, Xiaohan Gao, Guo-Hong Su, Jie Shen, ARong Jin, Peng Lv, Wenming Chen, Juan Li, Juan Du, Wen Gao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6925.
https://doi.org/10.1182/blood-2024-205155
Published: 2024
Journal Articles

The Evolving Treatment Paradigms and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Receive Autologous Stem Cell Transplantation in China: A Real-World Observational Study

Free
Xiaozhe Li, Juan Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6918.
https://doi.org/10.1182/blood-2024-202198
Published: 2024
Journal Articles

Clinical Characteristics and Prognostic Analysis of Non-Amyloid Monoclonal Gammopathy of Renal Significance (MGRS) in China

Free
Yuhang Song, Yang Liu, Junru Liu, Juan Li, Jin Lu, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4679.
https://doi.org/10.1182/blood-2024-206458
Published: 2024
Journal Articles

Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle

Free
Carys S. Johnson, Matthew Williams, Kendig Sham, Serena Belluschi, Wenjuan Ma, Xiaonan Wang, Winnie W. Y. Lau, Kerstin B. Kaufmann, Gabriela Krivdova, Emily F. Calderbank, Nicole Mende, Jessica McLeod, Giovanna Mantica, Juan Li, Charlotte Grey-Wilson, Michael Drakopoulos, Shaaezmeen Basheer, Shubhankar Sinha, Evangelia Diamanti, Christina Basford, Nicola K. Wilson, Steven J. Howe, John E. Dick, Berthold Göttgens, Anthony R. Green, Natalie Francis, Elisa Laurenti
Journal: Blood
Blood (2024) 144 (7): 729–741.
https://doi.org/10.1182/blood.2023021426
Published: 2024
Includes: Supplemental data
Journal Articles

On-Demand Plerixafor Added to High-Dose Cyclophosphamide and Pegylated Recombinant Human Granulocyte Colony-Stimulating Factorin the Mobilization of Patients with Multiple Myeloma: High Effectiveness and Affordable Cost

Free
Liqiong Hou, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6669.
https://doi.org/10.1182/blood-2023-173781
Published: 2023
Journal Articles

MASS-4 Is More Suitable Than MASS-3 for Prognostic Stratification in Transplant-Eligible Patients Withnewly Diagnosed Multiple Myeloma

Free
Fan Yang, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4695.
https://doi.org/10.1182/blood-2023-173813
Published: 2023
Journal Articles

One Case of Heavy Chain Deposition Disease Treated with Dara+KD Regimen and Literature Review

Free
Meilan Chen, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6773.
https://doi.org/10.1182/blood-2023-173818
Published: 2023